「Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody tocilizumab」 Atsushi Ogata, Atsuyoshi Morishima, Toru Hirano, Yoshihiro Hishitani, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka Annals of the Rheumatic Diseases 70:1164-1165, 2011
「Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab」
Sumiyuki Nishida, Tomio Kawasaki, Hirokazu Kashiwagi, Atsuyoshi Morishima, Yoshihiro Hishitani, Mari Kawai, Toru Hirano, Taeko Ishii, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki,
Atsushi Ogata, Yoshihiro Oka, Tadamitsu Kishimoto, Toshio Tanaka,
Modern Rheumatology 21:420-2,2011
「Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis.」
Ogata A, Hirano T, Hishitani Y, Tanaka T.
Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:27-42.
「Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis.」
Hishitani Y, Ogata A, Shima Y, et al.
Scandinavian journal of rheumatology. 2013;42(4):253-9.
「Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.」
Tanaka T, Hishitani Y, Ogata A.
Biologics. 2014 Apr 7;8:141-153.